Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences

Background—C-reactive protein (CRP) values predict atherothrombotic cardiovascular disease and type 2 diabetes mellitus. Associations between CRP and obesity, predominantly assessed anthropometrically, may partly explain these observations. Previous studies have been unable to control for genetic influences on CRP and obesity. The aim of this study was to examine the relationship between CRP and accurately measured body fat, lipids, apolipoproteins, blood pressure, and environmental and behavioral factors, independent of genetic influences. Methods and Results—One hundred ninety-four healthy female twins (age 57.2±7 years) were studied after excluding pairs with CRP values >10 mg/L. Total body fat and central abdominal fat (CAF) were measured by dual-energy x-ray absorptiometry. CRP concentration was strongly related to surrogate and direct measures of body fat (r =0.31 to 0.54, P <0.001), diastolic blood pressure (r =0.20, P =0.003), and lipid and apolipoprotein levels (r =0.21 to 0.51, P <0.008). Light-to-moderate alcohol consumers and nonusers of hormone replacement therapy (HRT) had lower CRP levels than abstainers and HRT users, respectively. In stepwise multiple regression analysis, CAF, triglycerides, apolipoprotein B, and HRT use explained 46% of the variance in circulating CRP. In analyses controlling for genetic influences in monozygotic twins, within-pair differences in CRP were associated with within-pair differences in total body fat (r =0.39, P <0.001), CAF (r =0.34, P =0.002), diastolic blood pressure (r =0.24, P =0.03), apolipoprotein AI (r =−0.33, P =0.01), HDL cholesterol (r =−0.42, P =0.001), and triglycerides (r =0.35, P =0.007). Conclusions—CRP was strongly related to total and central abdominal obesity, blood pressure, and lipid levels, independent of genetic influences. These relationships are likely to contribute significantly to prospective associations between CRP and type 2 diabetes and coronary events.

[1]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[2]  S. Haffner.  Insulin resistance, inflammation, and the prediabetic state. , 2003, The American journal of cardiology.

[3]  E. Poehlman,et al.  Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women , 2002, Circulation.

[4]  J. Kooner,et al.  C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites , 2001, Circulation.

[5]  Greta L. Hoetzer,et al.  Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. , 2003, Journal of applied physiology.

[6]  S. Humphries,et al.  A polymorphism in the human CRP gene influences basal and stimulated CRP levels: Implications for the prediction and pathogenesis of coronary heart disease , 2003 .

[7]  P. Manns,et al.  Physical activity, body fat, and serum c‐reactive protein in postmenopausal women with and without hormone replacement , 2003, American journal of human biology : the official journal of the Human Biology Council.

[8]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[9]  P. Ridker,et al.  Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. , 2002, Atherosclerosis.

[10]  E. Kraegen,et al.  PATHOGENESIS OF THE INSULIN RESISTANCE SYNDROME (SYNDROME X) , 1997, Clinical and experimental pharmacology & physiology.

[11]  T. Spector,et al.  Genes Versus Environment: The relationship between dietary fat and total and central abdominal fat , 1998, Diabetes Care.

[12]  C. Lamendola,et al.  Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein , 2002, Circulation.

[13]  C. Kluft,et al.  Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study , 2002, European Journal of Clinical Nutrition.

[14]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[15]  H. Brenner,et al.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.

[16]  E. Bruckert,et al.  Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. , 1999, Circulation.

[17]  T. Spector,et al.  Independent genetic factors determine the amount and distribution of fat in women after the menopause. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  S. Davis,et al.  New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  L. Heilbronn,et al.  Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  T. Spector,et al.  Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. , 2004, Clinical chemistry.

[21]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Robert J Glynn,et al.  Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.

[23]  E. Cauza,et al.  Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding , 2003, International Journal of Obesity.

[24]  C. Meisinger,et al.  C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. , 2003, Archives of internal medicine.

[25]  A. Hofman,et al.  Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[26]  E. Minar,et al.  Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[27]  C. Stehouwer,et al.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.

[28]  J. Danesh,et al.  Risk factors for coronary heart disease and acute-phase proteins. A population-based study. , 1999, European heart journal.

[29]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[30]  L. Retterstøl,et al.  A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease. , 2003, Atherosclerosis.

[31]  L. Kuller,et al.  Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. , 2001, American journal of epidemiology.

[32]  M. Pepys,et al.  Solid phase radioimmunoassays for human C-reactive protein. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[33]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[34]  D. Chisholm,et al.  Abdominal Fat and Insulin Resistance in Normal and Overweight Women: Direct Measurements Reveal a Strong Relationship in Subjects at Both Low and High Risk of NIDDM , 1996, Diabetes.

[35]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[36]  M. Pepys,et al.  Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. , 1998, Clinical chemistry.

[37]  R. Marfella,et al.  Association of low interleukin-10 levels with the metabolic syndrome in obese women. , 2003, The Journal of clinical endocrinology and metabolism.

[38]  R. Westendorp,et al.  Alcohol consumption and mortality among women. , 1995, The New England journal of medicine.

[39]  Hitoshi Nishizawa,et al.  Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue , 2003, Circulation.

[40]  A. Mainous,et al.  Relation between alcohol consumption and C-reactive protein levels in the adult US population. , 2002, The Journal of the American Board of Family Practice.

[41]  M. Cushman,et al.  Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. , 2002, Fertility and sterility.

[42]  J. Pankow,et al.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. , 2001, Atherosclerosis.

[43]  G. Yoshino,et al.  C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. , 2003, Metabolism: clinical and experimental.

[44]  D. Chisholm,et al.  Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography. , 2002, Obesity research.

[45]  S. Kaser,et al.  Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention , 2002, International Journal of Obesity.

[46]  A. Döring,et al.  Markers of inflammation in women on different hormone replacement therapies , 2003, Annals of medicine.

[47]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[48]  N. Sattar,et al.  Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians , 2001, International Journal of Obesity.

[49]  T. Spector,et al.  Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator? , 2003, Diabetes care.

[50]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[51]  J. Volanakis,et al.  HUMAN C-REACTIVE PROTEIN , 1997 .

[52]  M. Lathrop,et al.  Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. , 2002, Cardiovascular research.

[53]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[54]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[55]  G. Cooper,et al.  Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene , 2002, Genes and Immunity.

[56]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[57]  T. Spector,et al.  Moderate alcohol consumption, dietary fat composition, and abdominal obesity in women: evidence for gene-environment interaction. , 2003, The Journal of clinical endocrinology and metabolism.

[58]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[59]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[60]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[61]  Edward T H Yeh,et al.  Coming of age of C-reactive protein: using inflammation markers in cardiology. , 2003, Circulation.

[62]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[63]  Paul Kelly,et al.  Genetic and Environmental Influences on Total-Body and Central Abdominal Fat: The Effect of Physical Activity in Female Twins , 1999, Annals of Internal Medicine.